期刊文献+

29例临床药师参与儿童抗真菌治疗的会诊病例分析 被引量:1

Analysis of the Clinical Pharmacists Participating in the Consultation for 29 Antifungal Therapeutic Cases in Paediatrics
原文传递
导出
摘要 目的总结临床药师参与儿童真菌病例会诊的经验,探讨临床药师在儿童抗真菌治疗中的工作切入点。方法通过分析29例药师会诊儿童真菌感染病例,对患者性别、年龄、会诊科室,基础疾病,可疑感染部位,真菌病原学检查结果、会诊意见及采纳情况、治疗效果等进行统计分析。结果 29例患儿中1岁以内的婴幼儿为15例占51.72%;主要会诊科室为外科占总病例数的48.28%。29例病例中真菌培养阳性的共25例,其中霉菌4株(16.00%),念珠菌21株(84.00%)。会诊意见被临床采纳的28例,未被采纳的1例。21例采纳临床药师建议且进行抗真菌治疗的患者中,16例有效,占76.19%。结论临床药师参与儿童真菌治疗,能帮助临床医生制订更佳的真菌治疗方案,为患儿提供更好的用药安全保障。 OBJECTIVE To summarize the experience of antifungal therapeutic consultations in pediatric patients, which clinical pharmacists participating in and to explore the points that clinical pharmacists can involve into the pediatric antifungal therapeutic work. METHODS The medical records of the 29 cases with antifungal therapeutic consultations of clinical pharmacists were analyzed, and the data including gender, age, consultation departments, primary diseases, suspicious infection sites, fungus culture results, disposal opinions, suggestion adoption and treatment outcome were statistically analyzed. RESULTS Among the 29 cases, there were 15 infants (51.72%) younger than 1 year old. The main consultation department was surgical department which account for 48.28% cases. 25 cases had positive fungal culture results, in which 4 cases ( 16.00%) were molds and 21 cases ( 84.00%) were Candida. The suggestions of clinical pharmacists were adopted in 28 cases, except for one case. The 21 cases used antifungal drugs suggested by clinical pharmacies, 16 cases (76.19%) of them were supposed to be effective. CONCLUSION Clinical pharmacies participating in the antifungal therapy of pediatric patients may help clinicians developing better fungal treatment options and providing better drug safety guarantee for children.
作者 岑菡婧 欧阳珊 吴玮哲 莫小兰 杨彤 祁俊华 何艳玲 CEN Hanjing;OUYANG Shan;WU Weizhe;MO Xiaolan;YANG Tong;QI Junhua;HE Yanling(Department of Pharmacy, Guangzhou Women and Children' s Medical Center, Guangzhou, Guangdong 510623, China)
出处 《今日药学》 CAS 2019年第6期398-401,共4页 Pharmacy Today
基金 广州市医药卫生科技项目(20171A011254) 广东省医院药学研究基金(2016A25)
关键词 临床药师 真菌感染 药学会诊 儿童 clinical pharmacists fungal infection pharmaceutical consultation children
  • 相关文献

参考文献4

二级参考文献35

  • 1Dinleyici EC. Pediatric invasive ftmgal infections: realities, challenges,concerns, myths and hopes [J]. Expert Rev Anti Infect Ther, 2011, 9 (3) : 273-274.
  • 2Ldu'nbecher T, Groll AH. Invasive fungal infections in the pediatric population [J]. Expert Rev Anti Infect, 2011, 9 (3): 275-278.
  • 3Chapman RL, Faix RG. Invasive neonatal candidiasis: an overview [J]. Semin Perinatol, 2003, 27 (5) : 352-356.
  • 4Katragkou A. Best practice in treating infants and children with proven, probable or suspected invasive fungal infections [ J ]. Curr Opin Infect Dis, 2011, 24 (3): 225-229.
  • 5Theoklis EZ, Jesse A, Jaclyn C, et al. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis [ J ]. Clin Infect Dis, 2005, 41 (9) : 1232-1239.
  • 6Zaoutis TE, Heydon K, Localio R, et al. Outcomes attributable to neonatal candidiasis [J]. Clin Infect Dis, 21307, 44 (9): 1187-1193.
  • 7Zaoutis T. Candidemia in children[J].Curt Med Res, 2010, 26 (7) : 1761-1768.
  • 8Burgos A, Zaoufis TE, Dvorak CC, et al. Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contem- porary cases[J].Pediatrics, 2008, 121 (5): e1286-1294.
  • 9Zaoutis TE, Heydon K, Chu JH, et al. Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompmmised children in the United States, 20(30 [J]. Pediatrics, 2006, 117 (4): e711-716.
  • 10Zaoutis TE, Roilides E, Chiou CC, et al. Zygomycosis in children: a systematic review and analysis of reported cases [J]. Pediatr Infect Dis J, 2007,26 (8):723-727.

共引文献309

同被引文献12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部